H
Hannah S Hussey
Researcher at Charité
Publications - 13
Citations - 273
Hannah S Hussey is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 21 citations.
Papers
More filters
Journal ArticleDOI
Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies,Reshma Kassanjee,Petro Rousseau,Erna Morden,Leigh F. Johnson,Wesley Anthony Solomon,Nei-yuan Hsiao,Hannah S Hussey,Graeme Meintjes,Theuns Jacobs,Peter J Raubenheimer,Alexa Heekes,Pierre Dane,Jamy-Lee Bam,Mariette Smith,Wolfgang Preiser,David Pienaar,Marc Mendelson,J. Naudé,Neshaad Schreuder,Ayanda Trevor Mnguni,S. Le Roux,Katy Murie,Hans Prozesky,Hassan Mahomed,Liezel Rossouw,Sean Wasserman,D Maughan,Barry Smith,Jantjie Taljaard,Ntobeko A.B. Ntusi,Arifa Parker,Nicole Wolter,Waasila Jassat,Cheryl Cohen,Richard J Lessells,Robert Wilkinson,Melvin Moodley,M.R. Wolmarans,Andrew Boulle +39 more
TL;DR: The objective was to compare COVID‐19 outcomes in the Omicron‐driven fourth wave with prior waves in the Western Cape, assess the contribution of undiagnosed prior infection to differences in outcomes and determine whether protection against severe disease conferred by prior infection and/or vaccination was maintained.
Journal ArticleDOI
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
Nicole Wolter,Waasila Jassat,Sibongile Walaza,Richard Welch,Harry Moultrie,Michelle J. Groome,Daniel G. Amoako,J.S. Everatt,Jinal N. Bhiman,Cathrine Scheepers,Naume Tebeila,Nicola Chiwandire,Mignon du Plessis,N. Govender,Arshad Ismail,Allison J. Glass,Koleka Mlisana,W. Stevens,Florette K. Treurnicht,Kathleen Subramoney,Zinhle Makatini,Nei-yuan Hsiao,Raveen Parboosing,Jeannette Wadula,Hannah S Hussey,Mary-Ann Davies,Andrew Boulle,Anne von Gottberg,Cheryl Cohen +28 more
TL;DR: In this article , the presence/absence of the S-gene target was used as a proxy for SARS-CoV-2 variant/lineage for infections diagnosed using the TaqPath PCR assay between 1 October 2021 and 26 April 2022.
Journal ArticleDOI
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies,Erna Morden,Petro Rosseau,Juanita Arendse,Jamy-Lee Bam,Linda Boloko,Keith Cloete,Cheryl Cohen,Nicole Chetty,Pierre Dane,Alexa Heekes,Nei-yuan Hsiao,Mehreen B Hunter,Hannah S Hussey,Theuns Jacobs,Waasila Jassat,S. el Kariem,Reshma Kassanjee,Inneke Laenen,Sue Le Roux,Richard J Lessells,Hassan Mahomed,D Maughan,Graeme Meintjes,Marc Mendelson,Ayanda Trevor Mnguni,Melvin Moodley,Katy Murie,J. Naudé,Ntobeko A.B. Ntusi,M. Paleker,Arifa Parker,David Pienaar,Wolfgang Preiser,Hans Prozesky,Peter J Raubenheimer,Liezel Rossouw,Neshaad Schrueder,Barry Smith,Mariette Smith,Wesley Anthony Solomon,Gregory Symons,Jantjie Taljaard,Sean Wasserman,Robert J. Wilkinson,M.R. Wolmarans,Nicole Wolter,Andrew Boulle +47 more
TL;DR: In this article , the authors compared the clinical severity of Omicron BA.4/BA.5 infection with BA.1 and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the Western Cape, South Africa, using timing of infection to infer the lineage/variant causing infection.
Journal ArticleDOI
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
Hannah S Hussey,Mary-Ann Davies,Alexa Heekes,Carolyn Williamson,Ziyaad Valley-Omar,Diana Hardie,Stephen N.J. Korsman,Deelan Doolabh,Wolfgang Preiser,Tongai Maponga,Arash Iranzadeh,Sean Wasserman,Linda Boloko,Gregory Symons,Peter J Raubenheimer,Arifa Parker,Neshaad Schrueder,Wesley Solomon,P. Rousseau,Nicole Wolter,Waasila Jassat,Cheryl Cohen,Richard J Lessells,Robert J. Wilkinson,Andrew Boulle,Nei-yuan Hsiao +25 more
TL;DR: In this paper , a Cox regression was performed for the outcome of hospital admission in those who tested positive for SARS-CoV-2 on the Seegene AllplexTM assay from November 1 to December 14, 2021 in the Western Cape Province, South Africa, in the public sector.
Journal ArticleDOI
Varicella zoster virus-associated morbidity and mortality in Africa – a systematic review
Hannah S Hussey,Leila H Abdullahi,Jamie E. Collins,Rudzani Muloiwa,Gregory D. Hussey,Benjamin M. Kagina +5 more
TL;DR: There is lack of quality data that could be used to develop VZV control programmes, including vaccination, in Africa, and limited data on VzV seroprevalence in children showed very low seropositivity to anti-VZV antibodies.